FDA Requests Warnings on CAR-T Cell Therapies, Citing Second

The Food and Drug Administration is requesting that CAR-T cell therapies now come with a Boxed Warning about secondary malignancies that have been reported in patients who undergo these treatments.

Related Keywords

David Mitchell , Brucel Levine , Reuters , University Of Pennsylvania , Drug Administration , Twitter , National Institutes Of Health , Bristol Myers Squibb , Novartis , Perelman School Of Medicine , Boxed Warnings , National Institutes , Safety Labeling Change Notification , Patients Respond , Expert Weighs , Edward Netter Professor , Cancer Gene Therapy , Perelman School , Event Reporting System , Nature Medicine , Affordable Drugs , News , Myeloma , Leukemia , Lymphoma , Hodgkin Lymphoma , Blood Cancer , Fda , Cart Cell Therapies ,